Novo Integrated Sciences, Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the quarter ended May 31, 2024. The company cited the need for additional time to obtain and compile certain required information as the reason for the delay, stating that it could not be resolved without unreasonable effort and expense. Novo Integrated Sciences expects to file the report within the five-day extension period allowed by the SEC. The company confirmed that all other periodic reports have been filed as required, and there are no significant changes in results of operations from the corresponding period for the last fiscal year anticipated in the earnings statements to be included in the delayed report. The notification was signed by CEO Robert Mattacchione on July 15, 2024.

Novo Integrated Sciences, Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the quarter ended May 31, 2024. The company cited the need for additional time to obtain and compile certain required information as the reason for the delay, stating that it could not be resolved without unreasonable effort and expense. Novo Integrated Sciences expects to file the report within the five-day extension period allowed by the SEC. The company confirmed that all other periodic reports have been filed as required, and there are no significant changes in results of operations from the corresponding period for the last fiscal year anticipated in the earnings statements to be included in the delayed report. The notification was signed by CEO Robert Mattacchione on July 15, 2024.